Neuronal pentraxin receptor (NPTXR) isoform 1 (protein for the ADQDTIR peptide) has been shown to be a CSF biomarker of Alzheimer’s disease progression35 with levels differing between MCI and more advanced Alzheimer’s disease stages. This evidence concerns the gene NPTXR and early-onset autosomal dominant Alzheimer disease.